AntibioticMech

Browse · ANTIVIRAL

favipiravir

CHEBI:134722 ·resolve ·ANTIVIRAL ·EXACT REVIEWED

A member of the class of pyrazines that is pyrazine substituted by aminocarbonyl, hydroxy and fluoro groups at positions 2, 3 and 6, respectively. It is an anti-viral agent that inhibits RNA-dependent RNA polymerase of several RNA viruses and is approved for the treatment of influenza in Japan. — ChEBI

Classification

Strictly broader compounds or drug classes this molecule belongs to.

Chemical structure

Computed structure properties
Molecular formulaC5H4FN3O2
Charge0
Average mass157.104 Da
Monoisotopic mass157.02875 Da
SourceChEBI
InChIKeyZCGNOVWYSGBHAU-UHFFFAOYSA-N

SMILES

NC(=O)c1nc(F)cnc1O

InChI

InChI=1S/C5H4FN3O2/c6-2-1-8-5(11)3(9-2)4(7)10/h1H,(H2,7,10)(H,8,11)

Also called

Cross-references

Identifiers for this same structure in other resources. An accession that lands on two different structures in this corpus is withheld from both rather than shown here, since it names at most one of them.

Drug registries

Identifiers that name a drug rather than a structure. One of these can cover a parent compound, its salts and its stereoisomers, which this corpus keeps as separate records, so it is not an equivalence of structure.

Patents and articles

Documents about this compound. A patent covers a class and an article covers a topic; neither identifies a structure.

Activity roles

Every antimicrobial role a source asserts for this compound — the unreduced evidence behind its antimicrobial_class.

Source concepts

Every upstream concept that resolved to this record. The merge is the product: this is what shows ChEBI and CARD are describing the same structure.

Upstream concepts merged into this record
SourceNative IDLabelMinted CURIEVersion
CHEBI CHEBI:134722 favipiravir antibioticmech:chebi-90624c9d31 2026-08-30

Molecular targets

The molecular entity or process this compound acts on. Each target carries evidence — this is a mechanistic claim, not a classification.

influenza virus RNA-dependent RNA polymerase (via T-705RTP) VIRAL_PROTEIN MEASURED_TARGET_ASSOCIATION

Enzyme kinetics and primer-extension assays tested the active ribosyl-triphosphate metabolite T-705RTP. They did not measure direct binding of parent favipiravir to the polymerase. Evidence status: PRIMARY_EVIDENCE. Source: PRIMARY_LITERATURE 2013-08 (retrieved 2026-09-02).

Mechanism summary

Mode of action
VIRAL_POLYMERASE_INHIBITION microbial target — CURATOR: PMID:23917318 studied T-705RTP, the intracellularly formed ribosyl-triphosphate metabolite of favipiravir, rather than direct binding of the parent compound. T-705RTP competed with ATP and GTP, showed noncompetitive or mixed inhibition versus UTP and CTP, and after one incorporation into nascent influenza RNA inhibited further extension.

Record-level evidence

Curation history

  1. SEEDED_FROM_SOURCES 2026-08-30 · seed_from_sources

    Seeded from data/raw/ inventories (CHEBI)

  2. RESEEDED_FROM_SOURCES 2026-08-30 · seed_from_sources

    Re-seeded from updated data/raw/ inventories

  3. RESEEDED_FROM_SOURCES 2026-08-30 · seed_from_sources

    Re-seeded from updated data/raw/ inventories

  4. RESEEDED_FROM_SOURCES 2026-08-31 · seed_from_sources

    Re-seeded from updated data/raw/ inventories

  5. RESEEDED_FROM_SOURCES 2026-09-02 · seed_from_sources

    Re-seeded from updated data/raw/ inventories

  6. REVIEWED 2026-09-03 · codex · LLM-assisted

    Verified exact ChEBI parent-compound identity, structure, antiviral roles, and filing class; curator-confirmed viral-polymerase inhibition and added the measured influenza RdRp association with an explicit active-metabolite boundary.

  7. RESEEDED_FROM_SOURCES 2026-09-10 · seed_from_sources

    Re-seeded from updated data/raw/ inventories

Provenance

Seeded by scripts/seed_from_sources.py from the committed inventories in data/raw/. View the record (YAML).

Explore across X-Mech: MediaIngredientMech (favipiravir) · CultureMech · NaturalProductMech · PathwayMech · TraitMech